Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 23643812)

1.

Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression.

He W, Li X, Xu S, Ai J, Gong Y, Gregg JL, Guan R, Qiu W, Xin D, Gingrich JR, Guo Y, Chang G.

Biochem Biophys Res Commun. 2013 Jun 14;435(4):526-32. doi: 10.1016/j.bbrc.2013.04.074. Epub 2013 May 3.

PMID:
23643812
2.

Fibulin-1 is down-regulated through promoter hypermethylation and suppresses renal cell carcinoma progression.

Xiao W, Wang J, Li H, Guan W, Xia D, Yu G, Xiao H, Lang B, Ma X, Liu J, Zhang X, Ye Z, Xu H.

J Urol. 2013 Jul;190(1):291-301. doi: 10.1016/j.juro.2013.01.098. Epub 2013 Feb 4.

PMID:
23391467
3.

Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.

Lv D, Zhao W, Dong D, Qian XP, Zhang Y, Tian XJ, Zhang J.

Eur J Cancer. 2011 Sep;47(13):2068-76. doi: 10.1016/j.ejca.2011.04.021. Epub 2011 May 18.

PMID:
21600761
4.

The tumor-suppressive function of UNC5D and its repressed expression in renal cell carcinoma.

Lu D, Dong D, Zhou Y, Lu M, Pang XW, Li Y, Tian XJ, Zhang Y, Zhang J.

Clin Cancer Res. 2013 Jun 1;19(11):2883-92. doi: 10.1158/1078-0432.CCR-12-2978. Epub 2013 Apr 15.

5.

MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.

Cui L, Zhou H, Zhao H, Zhou Y, Xu R, Xu X, Zheng L, Xue Z, Xia W, Zhang B, Ding T, Cao Y, Tian Z, Shi Q, He X.

BMC Cancer. 2012 Nov 23;12:546. doi: 10.1186/1471-2407-12-546.

6.

Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma.

Nagata M, Sakurai-Yageta M, Yamada D, Goto A, Ito A, Fukuhara H, Kume H, Morikawa T, Fukayama M, Homma Y, Murakami Y.

Int J Cancer. 2012 Mar 15;130(6):1329-37. doi: 10.1002/ijc.26160. Epub 2011 Jul 21.

PMID:
21544807
7.

Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.

Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B, Latif F, Maher ER.

Cancer Res. 2005 Jun 1;65(11):4598-606.

8.

Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.

Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F, Maher ER.

Cancer Res. 2001 Oct 1;61(19):7277-81.

9.

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.

Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G, Zabarovsky ER.

Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7504-9. Epub 2001 Jun 5.

10.

Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage.

Zhang Q, Ying J, Li J, Fan Y, Poon FF, Ng KM, Tao Q, Jin J.

J Urol. 2010 Aug;184(2):731-7. doi: 10.1016/j.juro.2010.03.108. Epub 2010 Jun 19.

PMID:
20639048
11.

Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.

Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Ueno K, Yamamura S, Zaman MS, Khatri G, Chen Y, Saini S, Majid S, Deng G, Ishii N, Dahiya R.

Int J Cancer. 2011 Apr 15;128(8):1793-803. doi: 10.1002/ijc.25507.

PMID:
20549706
12.

The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.

Wu P, Zhang N, Wang X, Zhang C, Li T, Ning X, Gong K.

PLoS One. 2012;7(9):e45122. doi: 10.1371/journal.pone.0045122. Epub 2012 Sep 18.

13.

mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.

Christoph F, Hinz S, Kempkensteffen C, Schostak M, Schrader M, Miller K.

J Urol. 2007 Dec;178(6):2655-9. Epub 2007 Oct 22.

PMID:
17945286
14.

CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma.

Kagara I, Enokida H, Kawakami K, Matsuda R, Toki K, Nishimura H, Chiyomaru T, Tatarano S, Itesako T, Kawamoto K, Nishiyama K, Seki N, Nakagawa M.

J Urol. 2008 Jul;180(1):343-51. doi: 10.1016/j.juro.2008.02.044. Epub 2008 May 21.

PMID:
18499164
15.

Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.

Tong JH, Ng DC, Chau SL, So KK, Leung PP, Lee TL, Lung RW, Chan MW, Chan AW, Lo KW, To KF.

BMC Cancer. 2010 Jun 3;10:253. doi: 10.1186/1471-2407-10-253.

16.

Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.

Yamada Y, Hidaka H, Seki N, Yoshino H, Yamasaki T, Itesako T, Nakagawa M, Enokida H.

Cancer Sci. 2013 Mar;104(3):304-12. doi: 10.1111/cas.12072. Epub 2012 Dec 29.

PMID:
23176581
17.

Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.

Bennett KL, Campbell R, Ganapathi S, Zhou M, Rini B, Ganapathi R, Neumann HP, Eng C.

Genes Chromosomes Cancer. 2011 Aug;50(8):654-61. doi: 10.1002/gcc.20887. Epub 2011 May 16.

18.

Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma.

Yamada D, Kikuchi S, Williams YN, Sakurai-Yageta M, Masuda M, Maruyama T, Tomita K, Gutmann DH, Kakizoe T, Kitamura T, Kanai Y, Murakami Y.

Int J Cancer. 2006 Feb 15;118(4):916-23.

PMID:
16152585
19.

A recombinant adenovirus expressing p7(Kip1) induces cell cycle arrest and apoptosis in human 786-0 renal carcinoma cells.

Katner AL, Gootam P, Hoang QB, Gnarra JR, Rayford W.

J Urol. 2002 Aug;168(2):766-73.

PMID:
12131366
20.

Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.

Oguro T, Ishibashi K, Sugino T, Hashimoto K, Tomita S, Takahashi N, Yanagida T, Haga N, Aikawa K, Suzutani T, Yamaguchi O, Kojima Y.

Eur J Cancer. 2013 May;49(7):1715-24. doi: 10.1016/j.ejca.2012.11.038. Epub 2012 Dec 27.

PMID:
23274199
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk